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was markedly reduced compared with
isozyme A of normal mucosa. Heating of
enzyme extracts at 50°C for 30 min before
electrophoresis caused no change in the
electrophoretic mobilities of any of the
isozymes but slightly reduced their staining
intensities. On the other hand, after heating
at 55°C for 30 min, isozymes A and C were
hardly detectable on subsequent staining.
Incubation of enzyme extracts with neura-
minidase at 37°C for 18 h caused no signi-
ficant changes either in the mobility or in the
staining reaction of any of these isozymes
from normal and experimental tissuse.
Isozymes A and C appeared to be soluble
enzymes whereas isozyme B, due to its
extraction in 0.2% Triton X-100, seemed to
be bound to lysosomes.
IS ALKYLATION OF NICOTINAMIDE
THE CAUSE OF LIVER NECROSIS
THAT FOLLOWS LARGE DOSES OF
HEPATOCARCINOGENS? R. SCHOEN-
TAL, Department of Pathology, Royal
Veterinary College, London.
Large doses of hepatocarcinogens cause
liver necrosis, not seen after doses which can
induce tumours. In the course of their
metabolism, many hepatocarcinogens yield
alkylating entities, known to alkylate nucleic
acids, proteins and other cell constituents,
including nicotinamide (Schein etal., Biochem.
Pharmac., 1973, 22, 2625; Chu and Lawley,
Chem. Biol. Interactions, 1974, 8, 65).
Alkylated derivatives of nicotinamide cannot
be utilized for the biosynthesis of NAD
cofactors, essential for cell survival. Deple-
tion ofNAD in the liver occurs after pyrrolizi-
dine alkaloids, dimethylnitrosamine, strepto-
zotocin etc., and can be prevented by
pretreatment with nicotinamide, which in
some cases prevents also the cytotoxic
effects.
More information is needed as regards the
role of alkylated derivatives of nicotinamide
in cell death and in relation to tumour
induction.
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CHEMICAL BASIS FOR THE
RELATIONSHIP BETWEEN MUTA-
GENESIS AND CARCINOGENESIS.
P. BROOKES, Pollards Wood Research
Station, Bucks.
A relationship between carcinogenesis and
mutagenesis was first suggested by T. Boveri
in 1917 and K. H. Bauer in 1928 proposed the
somatic mutation theory of cancer, although
at that time the nature ofthe genetic material
was unknown. The recognition of the
biological role of DNA, following the elucid-
ation of its structure by Crick and Watson in
1953, did not immediately revive the support
for the mutation theory of cancer which had
been under strong attack. This was mainly
the result of the repeated failure to demon-
strate mutation with such classic carcinogens
as the polycyclic hydrocarbons and aromatic
amines. Prior to 1940 polycyclic hydro-
carbons were almost the only well studied
group ofcarcinogens. During the subsequent
20 years, however, the number and variety of
chemical substances both synthetic and
naturally occurring, which were shown to
induce cancer in animals, became so great
that it seemed impossible to conceive of any
common mechanism of tumour induction.
The breakthrough came with the recog-
nition of the importance of metabolism in
converting the applied carcinogen to the
biologically active form. One class of car-
cinogen, namely the biological alkylating
agents, did not require metabolic activation
and a study oftheir mechanism of action had
implicated DNA reaction. It seemed
possible therefore that all carcinogens might
act via electrophilic intermediates similar to
those involved in alkylation and that these
" ultimate carcinogens" might modify
cellular DNA.
A great deal of evidence is now available
which supports both the above postulates.
In the case of the aromatic amines the
identification of N-hydroxy metabolites by
the Millers led to an understanding of254 B.A.C.R. 16TH ANNUAL GENERAL MEETING
their metabolic activation. In the case of
acetylaminofluoro it appears that the ultimate
carcinogen is the sulphate ester of the
N-hydroxy metabolite. The dialkylnitro-
samines represent a class of chemically inert,
potent carcinogens of simple structure. The
mechanism of activation of these compounds
involves metabolic conversion to a monoalkyl
nitrosamine which spontaneously breaks
down to yield an alkyl carbonium ion. The
related nitrosamides (e.g. N-methyl-N-
nitrosourea) and nitrosamidines (e.g. MNNG)
are activated chemically by sulphydryl or
hydroxyl groups to yield carbonium ions.
The nature of the ultimate carcinogen
derived from the polycyclic hydrocarbons is
still in doubt. However, it seems likely that
an epoxide is involved and this is probably
also the case for the naturally occurring liver
carcinogen, aflatoxin.
The feature of the above and many other
mechanisms of metabolic activation is the
production of an electrophilic species which
attacks DNA. A study of the chemistry of
DNA reaction by a variety of carcinogens has
suggested that not all reactions are of equal
biological significance. In particular,
methylation of the 0-6 position of guanine,
although quantitatively a minor product of
DNA reaction, has been implicated in the
mutagenic and tumour initiating action of
methylating carcinogens.
While many gaps remain in our under-
standing of the mechanism of carcinogene3is,
the concept of DNA reaction and hence the
relationship between mutagenesis and car-
cinogenesis has proved a valuable stimulus
for further investigation.
SCREENING FOR CARCINOGENS
WITH BACTERIA. B. A. BRIDGES, MRC
Cell Mutation Unit, University of Sussex.
Bacterial systems for detecting mutagens
have been developed to a high degree of
sensitivity in recent years (e.g. Bridges et al.,
Chem-Biol. Interactions, 1972, 5, 77; Ames
et al., Proc. natn. Acad. Sci. U.S.A., 1973, 70,
782).
Since they can be used in conjunction
with mammalian microsomal preparations to
allow for metabolic activation the correlation
of mutagenicity and carcinogenicity is now
impressive (e.g. Ames et al., Proc. natn. Acad.
Sci. U.S.A., 1973, 70, 2281). Mutagens can
be broadly divided into 3 classes. The first
consists of agents which cause base pair
substitutions in DNA as a consequence of
replication errors, e.g. base analogues and
some (but not all) alkylating agents (such as
ethyl methanesulphonate and " nitrosoguani-
dine "). The second class also causes base
pair substitution mutations but they arise as
errors of repair rather than replication (e.g.
ionizing and ultra violet radiations, methyl
methanesulphonate, vinyl chloride, 7-
bromomethylbenzanthracene). Members of
the third class cause insertions or deletions of
base pairs (e.g. 2-aminofluorene). Most mem-
bers of all 3 classes are carcinogenic.
Bacterial systems can detect and differentiate
the 3 classes and predict possible carcino-
genicity. They may also detect chemicals
which damage DNA by causing cross links
but which are not particularly mutagenic
(e.g. heliotrine, mitomycin C). The carcino-
genic activity of such agents is unclear.
Bacterial systems cannot at present predict
which mammalian organs are likely to be
effected although both in vivo and in vitro
systems may be envisaged which might
enable this to be achieved.
A few carcinogens, the action of which is
based on physical properties (e.g. asbestos),
may not be detected, together with some
which are specific for the mammalian
chromosomal structure. These might be
better detected with cultured mammalian
cell systems currently under development.
A positive result in a bacterial system
should lead to an examination of the meta-
bolic fate of the chemical in mammals and
man, and possibly to full-scale tests with
laboratory animals. Bacterial tests are
likely to be most useful with industrial
chemicals, especially those already in use,
where the large numbers that need to be
tested effectively preclude animal tests
except for those particularly widely used.
CARCINOGENIC AND MUTAGENIC
ACTIVITY OF CHROMIUM CONTAIN-
ING MATERIALS. L. S. LEVY, Division
of Social Medicine and S. VENITT, Division of
Chemical Carcinogenesis, Pollards Wood
Research Station. Bucks.
Early in this century, observations oflung
cancer were made among workers in the
German bichromate producing industry.
The results were not reported until the 1930s